Table 3

Cause of death according to type of graft source

Cause of deathDeaths within 100 days per graft source (%)
Deaths later than 100 days per graft source (%)
HLA-matched related bone marrow or peripheral bloodHLA-mismatched related bone marrow or peripheral bloodUnrelated bone marrowUnrelated cord bloodHLA-matched related bone marrow or peripheral bloodHLA-mismatched related bone marrow or peripheral bloodUnrelated bone marrowUnrelated cord blood
Primary disease 11 (28) 9 (35) 6 (18) 15 (30) 19 (37) 16 (53) 10 (42) 
Treatment-related         
    GVHD 3 (8) 1 (4) 2 (6) 2 (4) 4 (8) 2 (7) 1 (4) 
    Infection 7 (18) 5 (19) 9 (27) 12 (24) 9 (17) 4 (13) 5 (21) 
    Organ failure 12 (30) 3 (12) 13 (39) 11 (22) 9 (17) 4 (13) 0 (0) 
    Others 6 (15) 7 (27) 3 (9) 10 (20) 7 (13) 4 (13) 4 (17) 
Undetermined 1 (3) 1 (4) 0 (0) 0 (0) 4 (8) 0 (0) 4 (17) 
Total no. of deaths 40 (100) 26 (100) 33 (100) 50 (100) 52 (100) 30 (100) 24 (100) 
Patients at risk 154 43 99 90 113 17 66 39 
Cause of deathDeaths within 100 days per graft source (%)
Deaths later than 100 days per graft source (%)
HLA-matched related bone marrow or peripheral bloodHLA-mismatched related bone marrow or peripheral bloodUnrelated bone marrowUnrelated cord bloodHLA-matched related bone marrow or peripheral bloodHLA-mismatched related bone marrow or peripheral bloodUnrelated bone marrowUnrelated cord blood
Primary disease 11 (28) 9 (35) 6 (18) 15 (30) 19 (37) 16 (53) 10 (42) 
Treatment-related         
    GVHD 3 (8) 1 (4) 2 (6) 2 (4) 4 (8) 2 (7) 1 (4) 
    Infection 7 (18) 5 (19) 9 (27) 12 (24) 9 (17) 4 (13) 5 (21) 
    Organ failure 12 (30) 3 (12) 13 (39) 11 (22) 9 (17) 4 (13) 0 (0) 
    Others 6 (15) 7 (27) 3 (9) 10 (20) 7 (13) 4 (13) 4 (17) 
Undetermined 1 (3) 1 (4) 0 (0) 0 (0) 4 (8) 0 (0) 4 (17) 
Total no. of deaths 40 (100) 26 (100) 33 (100) 50 (100) 52 (100) 30 (100) 24 (100) 
Patients at risk 154 43 99 90 113 17 66 39 

HLA indicates human leukocyte antigen; GVHD, graft-versus-host disease.

Data are number of deaths to total deaths (%) after transplantation in the group according to type of graft source. Percentages are not provided for groups having fewer than 10 patients in total.

or Create an Account

Close Modal
Close Modal